Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers - PubMed (original) (raw)
Affiliations
- PMID: 10690545
Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers
D H Moore et al. Clin Cancer Res. 2000 Feb.
Abstract
The DNA base excision repair pathway is responsible for the repair of alkylation and oxidative DNA damage. A crucial step in the base excision repair pathway involves the cleavage of an apurinic/apyrimidinic (AP) site in DNA by an AP endonuclease (APE). The major AP endonuclease in mammalian cells is APE/ref-1, a multifunctional enzyme that acts not only as an AP endonuclease but as a redox-modifying factor for a variety of transcription factors. The purpose of this study was to determine the expression of APE/redox factor-1 (ref-1) in ovarian tissues, particularly ovarian cancers. Formalin-fixed, paraffin-embedded specimens of ovarian tissues (normal, various benign conditions, and epithelial cancers) were studied using both polyclonal and monoclonal antibodies to APE/ref-1. The relationship between APE/ref-1 protein levels and DNA repair activity was studied in ovarian Hey and Hey-C2 cell lines using Western blot and a specific AP-site oligonucleotide cleavage assay. Hey and Hey-C2 cells were fractionated, and the nuclear and cytoplasmic extracts were quantitated for protein levels and assessed for APE/ref-1 with Western blot. Normal ovarian tissues consistently demonstrated strong nuclear staining of the surface epithelium, epithelial inclusions, corpora lutea and albicantia, and stroma. Cytoplasmic staining was absent. A similar pattern was seen for benign conditions including endometriosis. Low malignant potential ovarian cancers stained in a pattern similar to normal ovarian and nonneoplastic tissues; however, two specimens also had areas of cytoplasmic staining. Epithelial ovarian cancers were remarkably different from all other ovarian tissues studied. Both nuclear and cytoplasmic staining of the malignant epithelium were seen and ranged from strong to weak, often with considerable staining heterogeneity within the same tumor. The AP-site oligonucleotide cleavage assay indicated that APE/ref-1 protein levels correlate well with DNA repair activity. The increased levels of APE/ref-1 in the Hey-C2 cells was mainly attributable to increased cytoplasmic enzyme. APE/ref-1 immunoreactivity is altered in malignant ovarian tumors. Further studies will determine whether the altered expression and subcellular location reflect changes in redox regulatory functions.
Similar articles
- Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
Kelley MR, Cheng L, Foster R, Tritt R, Jiang J, Broshears J, Koch M. Kelley MR, et al. Clin Cancer Res. 2001 Apr;7(4):824-30. Clin Cancer Res. 2001. PMID: 11309329 - Going APE over ref-1.
Evans AR, Limp-Foster M, Kelley MR. Evans AR, et al. Mutat Res. 2000 Oct 16;461(2):83-108. doi: 10.1016/s0921-8777(00)00046-x. Mutat Res. 2000. PMID: 11018583 Review. - The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
Fishel ML, Kelley MR. Fishel ML, et al. Mol Aspects Med. 2007 Jun-Aug;28(3-4):375-95. doi: 10.1016/j.mam.2007.04.005. Epub 2007 May 3. Mol Aspects Med. 2007. PMID: 17560642 Review.
Cited by
- Base Excision Repair: Mechanisms and Impact in Biology, Disease, and Medicine.
Gohil D, Sarker AH, Roy R. Gohil D, et al. Int J Mol Sci. 2023 Sep 16;24(18):14186. doi: 10.3390/ijms241814186. Int J Mol Sci. 2023. PMID: 37762489 Free PMC article. Review. - Revisiting Two Decades of Research Focused on Targeting APE1 for Cancer Therapy: The Pros and Cons.
Malfatti MC, Bellina A, Antoniali G, Tell G. Malfatti MC, et al. Cells. 2023 Jul 20;12(14):1895. doi: 10.3390/cells12141895. Cells. 2023. PMID: 37508559 Free PMC article. Review. - The DNA repair function of BCL11A suppresses senescence and promotes continued proliferation of triple-negative breast cancer cells.
Vickridge E, Faraco CCF, Tehrani PS, Ramdzan ZM, Rahimian H, Leduy L, Gingras AC, Nepveu A. Vickridge E, et al. NAR Cancer. 2022 Sep 28;4(4):zcac028. doi: 10.1093/narcan/zcac028. eCollection 2022 Dec. NAR Cancer. 2022. PMID: 36186110 Free PMC article. - Base excision repair accessory factors in senescence avoidance and resistance to treatments.
Vickridge E, Faraco CCF, Nepveu A. Vickridge E, et al. Cancer Drug Resist. 2022 Jun 22;5(3):703-720. doi: 10.20517/cdr.2022.36. eCollection 2022. Cancer Drug Resist. 2022. PMID: 36176767 Free PMC article. Review. - Nucleases as molecular targets for cancer diagnosis.
Balian A, Hernandez FJ. Balian A, et al. Biomark Res. 2021 Nov 22;9(1):86. doi: 10.1186/s40364-021-00342-4. Biomark Res. 2021. PMID: 34809722 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous